<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <originChamber>House</originChamber>
    <recordedVotes />
    <congress>114</congress>
    <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.</title>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2015-05-22</actionDate>
    </latestAction>
    <notes />
    <updateDate>2018-11-21T21:23:11Z</updateDate>
    <amendments />
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-05-19T14:05:50Z</date>
            </item>
          </activities>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-05-22T15:10:37Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 161, Number 77 (Tuesday, May 19, 2015)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. SHIMKUS:H.R. 2428.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.[Page H3389]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills>
      <item>
        <type>HR</type>
        <number>6</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2015-07-13</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
      <item>
        <type>S</type>
        <number>2188</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2015-10-21</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>Rare Disease Innovation Act</latestTitle>
      </item>
      <item>
        <type>HR</type>
        <number>34</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2016-12-13</actionDate>
          <text>Became Public Law No: 114-255.</text>
        </latestAction>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
    </relatedBills>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <updateDate>2015-05-19T04:00:00Z</updateDate>
          <actionDesc>Introduced in House</actionDesc>
          <lastSummaryUpdateDate>2015-09-03T16:06:03Z</lastSummaryUpdateDate>
          <text><![CDATA[<p>This bill amends the Federal Food, Drug, and Cosmetic Act to expand the humanitarian device exemption to authorize the Food and Drug Administration (FDA) to exempt from effectiveness requirements certain medical devices intended to benefit fewer than 8,000 individuals. Currently, the FDA may exempt devices intended to benefit fewer than 4,000 individuals.</p> Within 18 months of enactment of this Act, the FDA must define &ldquo;probable benefit&rdquo; for these devices.]]></text>
          <name>Introduced in House</name>
          <actionDate>2015-05-19</actionDate>
        </item>
      </billSummaries>
    </summaries>
    <createDate>2015-05-20T08:46:22Z</createDate>
    <billNumber>2428</billNumber>
    <billType>HR</billType>
    <cosponsors />
    <version>1.0.0</version>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <actionDate>2015-05-22</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <links />
        <text>Introduced in House</text>
        <actionDate>2015-05-19</actionDate>
      </item>
      <item>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <links />
        <text>Introduced in House</text>
        <actionDate>2015-05-19</actionDate>
      </item>
    </actions>
    <laws />
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <chamberName />
        <parentTitleType />
        <chamberCode />
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to humanitarian device exemption applications.</title>
      </item>
    </titles>
    <cboCostEstimates />
    <sponsors>
      <item>
        <byRequestType />
        <lastName>SHIMKUS</lastName>
        <middleName>M.</middleName>
        <state>IL</state>
        <identifiers>
          <bioguideId>S000364</bioguideId>
          <lisID>1527</lisID>
          <gpoId>7939</gpoId>
        </identifiers>
        <bioguideId>S000364</bioguideId>
        <fullName>Rep. Shimkus, John [R-IL-15]</fullName>
        <firstName>JOHN</firstName>
        <district>15</district>
        <party>R</party>
      </item>
    </sponsors>
    <committeeReports />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <introducedDate>2015-05-19</introducedDate>
    <calendarNumbers />
    <policyArea>
      <name>Health</name>
    </policyArea>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

